Therapeutic options in neuromyelitis optica spectrum disorders

被引:27
作者
Kitley, Joanna [1 ]
Palace, Jackie [2 ]
机构
[1] Southampton Gen Hosp, Wessex Neurol Ctr, Dept Neurol, Southampton SO9 4XY, Hants, England
[2] Univ Oxford, Oxford Univ Hosp NHS Trust, Nuffield Dept Clin Neurosci, Level 3 West Wing, Oxford, England
关键词
NMOSD; treatment; AQP4-Ab; neuromyelitis optica spectrum disorders; aquaporin-4; NMO; Neuromyelitis optica; INTERLEUKIN-6 RECEPTOR BLOCKADE; PLASMA-EXCHANGE; INTRAVENOUS IMMUNOGLOBULIN; ANTI-AQUAPORIN-4; ANTIBODY; MYCOPHENOLATE-MOFETIL; DIAGNOSTIC-CRITERIA; POSITIVE PATIENTS; ACUTE RELAPSES; AQUAPORIN-4; NMO;
D O I
10.1586/14737175.2016.1150178
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Neuromyelitis optica is a relapsing inflammatory disorder of the central nervous system that manifests predominantly with attacks of optic neuritis and longitudinally extensive transverse myelitis; attacks are often severe. In contrast to multiple sclerosis, a secondary progressive phase is rare, and disability in neuromyelitis optica spectrum disorders is related to relapses. Thus, prompt and effective treatment of relapses, and early initiation of long-term immunosuppression to prevent subsequent attacks is required in order to prevent morbidity and mortality.
引用
收藏
页码:319 / 329
页数:11
相关论文
共 107 条
[71]   Isolated new onset 'atypical' optic neuritis in the NMO clinic: serum antibodies, prognoses and diagnoses at follow-up [J].
Piccolo, L. ;
Woodhall, M. ;
Tackley, G. ;
Jurynczyk, M. ;
Kong, Y. ;
Domingos, J. ;
Gore, R. ;
Vincent, A. ;
Waters, P. ;
Leite, M. I. ;
Palace, J. .
JOURNAL OF NEUROLOGY, 2016, 263 (02) :370-379
[72]   Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study [J].
Pittock, Sean J. ;
Lennon, Vanda A. ;
McKeon, Andrew ;
Mandrekar, Jay ;
Weinshenker, Brian G. ;
Lucchinetti, Claudia F. ;
O'Toole, Orna ;
Wingerchuk, Dean M. .
LANCET NEUROLOGY, 2013, 12 (06) :554-562
[73]   Lack of Response to Monoclonal Antibody Therapy in Neuromyelitis Optica [J].
Qian, Peiqing ;
Cross, Anne H. ;
Naismith, Robert T. .
ARCHIVES OF NEUROLOGY, 2011, 68 (09) :1207-1209
[74]   Azathioprine plus corticosteroid treatment in Chinese patients with neuromyelitis optica [J].
Qiu, Wei ;
Kermode, Allan G. ;
Li, Rui ;
Dai, Yongqiang ;
Wang, Yuge ;
Wang, Jingqi ;
Zhong, Xiaonan ;
Li, Caixia ;
Lu, Zhengqi ;
Hu, Xueqiang .
JOURNAL OF CLINICAL NEUROSCIENCE, 2015, 22 (07) :1178-1182
[75]   Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate [J].
Ramanathan, Ramnath Santosh ;
Malhotra, Konark ;
Scott, Thomas .
BMC NEUROLOGY, 2014, 14
[76]   Long-term Therapy With Interleukin 6 Receptor Blockade in Highly Active Neuromyelitis Optica Spectrum Disorder [J].
Ringelstein, Marius ;
Ayzenberg, Ilya ;
Harmel, Jens ;
Lauenstein, Ann-Sophie ;
Lensch, Eckart ;
Stoegbauer, Florian ;
Hellwig, Kerstin ;
Ellrichmann, Gisa ;
Stettner, Mark ;
Chan, Andrew ;
Hartung, Hans-Peter ;
Kieseier, Bernd ;
Gold, Ralf ;
Aktas, Orhan ;
Kleiter, Ingo .
JAMA NEUROLOGY, 2015, 72 (07) :756-763
[77]   Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis [J].
Roemer, Shanu F. ;
Parisi, Joseph E. ;
Lennon, Vanda A. ;
Benarroch, Eduardo E. ;
Lassmann, Hans ;
Bruck, Wolfgang ;
Mandler, Raul N. ;
Weinshenker, Brian G. ;
Pittock, Sean J. ;
Wingerchuk, Dean M. ;
Lucchinetti, Claudia F. .
BRAIN, 2007, 130 :1194-1205
[78]   Rheumatoid arthritis medications and lactation [J].
Sammaritano, Lisa R. ;
Bermas, Bonnie L. .
CURRENT OPINION IN RHEUMATOLOGY, 2014, 26 (03) :354-360
[79]   Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders [J].
Sato, Douglas Kazutoshi ;
Callegaro, Dagoberto ;
Lana-Peixoto, Marco Aurelio ;
Waters, Patrick J. ;
de Haidar Jorge, Frederico M. ;
Takahashi, Toshiyuki ;
Nakashima, Ichiro ;
Apostolos-Pereira, Samira Luisa ;
Talim, Natalia ;
Simm, Renata Faria ;
Martins Lino, Angelina Maria ;
Misu, Tatsuro ;
Leite, Maria Isabel ;
Aoki, Masashi ;
Fujihara, Kazuo .
NEUROLOGY, 2014, 82 (06) :474-481
[80]   IFNβ-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum [J].
Shimizu, J. ;
Hatanaka, Y. ;
Hasegawa, M. ;
Iwata, A. ;
Sugimoto, I. ;
Date, H. ;
Goto, J. ;
Shimizu, T. ;
Takatsu, M. ;
Sakurai, Y. ;
Nakase, H. ;
Uesaka, Y. ;
Hashida, H. ;
Hashimoto, K. ;
Komiya, T. ;
Tsuji, S. .
NEUROLOGY, 2010, 75 (16) :1423-1427